Arcellx (ACLX) Net Equity Issued and Repurchased (2021 - 2025)
Arcellx's (ACLX) quarterly Net Equity Issued and Repurchased came in at $123.8 million in Q3 2025, up 1486.54% quarter-over-quarter from $7.8 million in Q2 2025.
Arcellx (ACLX) Net Equity Issued and Repurchased (2021 - 2025) Analysis & Trends
Arcellx's Net Equity Issued and Repurchased history runs 3 years deep, the most recent figure standing at $123.8 million for Q3 2025.
- On a quarterly basis, Net Equity Issued and Repurchased changed N/A year-over-year to $123.8 million in Q3 2025; TTM through Dec 2025 was $131.5 million, a N/A change from a year earlier, with the FY2025 full-year figure at $131.6 million, changed N/A from the prior year.
- Net Equity Issued and Repurchased grew to $123.8 million in Q3 2025 per ACLX's latest filing, from $7.8 million in the prior quarter.
- Across five years, Net Equity Issued and Repurchased topped out at $129.2 million in Q1 2022 and bottomed at $7.8 million in Q2 2025.
- The 3-year median for Net Equity Issued and Repurchased is $81.8 million (2021), against an average of $76.0 million.
- Biggest YoY gain for Net Equity Issued and Repurchased was 57.98% in 2022; the steepest drop was 57.98% in 2022.
- Year by year, Net Equity Issued and Repurchased stood at $37.4 million in 2021, then surged by 245.69% to $129.2 million in 2022, then fell by 4.19% to $123.8 million in 2025.
- Per Business Quant, the three latest ACLX Net Equity Issued and Repurchased figures stand at $123.8 million (Q3 2025), $7.8 million (Q2 2025), and $129.2 million (Q1 2022).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Equity Issued and Repurchased (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | - |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | - |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 163.10 Mn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | 141.90 Mn |
| 10 | Arcellx | 6.48 Bn | 6.48 Bn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2025 | 123.75 Mn |
| Sep 30, 2025 | 123.75 Mn |
| Jun 30, 2025 | 7.80 Mn |
| Jun 30, 2025 | 7.80 Mn |
| Mar 31, 2022 | 129.16 Mn |
| Mar 31, 2022 | 129.16 Mn |
| Jun 30, 2021 | 37.36 Mn |
| Jun 30, 2021 | 37.36 Mn |
| Mar 31, 2021 | 81.76 Mn |
| Mar 31, 2021 | 81.76 Mn |